DNA
Ginkgo Bioworks Holdings
8.60$
-8.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -82.4% | -177.2% | -80.9% | -52.8% | -117.5% | -140.8% | -100.5% | |
| 19.8% | 18.1% | 9.3% | 8.9% | 28.5% | 27.8% | 34.7% | |
| 1.4% | 0.6% | 511.7% | 404.1% | 91.4% | 49.5% | 47.9% | |
| 98.4% | 4.5% | 512.6% | 389.3% | – | – | – | |
| 19.5% | -34.6% | -19.6% | -7.7% | 11.9% | -39.5% | -25.9% | |
| 41.0% | 75.4% | 18.0% | 10.9% | 16.2% | 27.5% | 4.5% | |
| -137.7% | -87.6% | -23.3% | -14.1% | -32.1% | -27.4% | -141.2% | |
| – | – | 481.1% | 0.2% | – | – | – | |
| -0.8% | 118.8% | -8.0% | -5.2% | 0.0% | 0.0% | 11.4% | |
| 366.5% | -1.0% | -0.4% | 20.5% | -0.5% | -0.4% | -0.2% | |
| 757.4% | 117.8% | 488.8% | 20.0% | -1.3% | -0.8% | 10.4% | |
| 537.3% | -146.9% | 384.6% | -46.8% | -151.1% | -169.1% | -231.1% | |
| -123.4% | -252.6% | -98.9% | -63.7% | -133.7% | -168.3% | -105.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.